lower
respiratori
tract
infect
primarili
pneumonia
lead
caus
death
worldwid
infant
children
approxim
million
case
childhood
communityacquir
pneumonia
cap
year
cap
major
caus
morbid
mortal
among
children
develop
countri
time
common
develop
countri
bacteria
princip
caus
cap
children
wide
investig
case
howev
still
consider
deficit
aetiolog
diagnosi
result
unnecessari
inappropri
antibiot
prescript
clear
involv
virus
cap
underestim
due
lack
understand
viral
etiolog
clinic
set
addit
appropri
sampl
infant
young
children
critic
aetiolog
diagnosi
cap
lung
rare
sampl
directli
sputum
repres
lowerairway
secret
rare
obtain
children
among
children
cap
may
caus
wide
varieti
microb
includ
typic
bacteria
eg
streptococcu
pneumonia
atyp
bacteria
mycobacterium
tuberculosi
fungi
viral
infect
also
involv
episod
cap
children
year
old
older
children
studi
cap
tradit
focus
littl
viral
caus
studi
includ
extens
appropri
evalu
role
virus
aetiolog
cap
develop
countri
includ
china
recent
year
introduct
betterqu
diagnost
test
markedli
improv
abil
detect
multipl
viral
pathogen
shift
attent
import
role
virus
caus
cap
accord
previou
studi
twothird
childhood
pneumonia
case
associ
viral
infect
respiratori
syncyti
viru
rsv
influenza
viru
ifv
rhinoviru
rv
human
metapneumoviru
hmpv
parainfluenza
virus
piv
common
virus
associ
pneumonia
addit
role
cytomegaloviru
cmv
herp
virus
hhv
recent
identifi
human
coronavirus
human
bocaviru
hbov
caus
cap
infant
children
remain
controversi
far
pathogen
profil
hhv
role
cap
among
infant
young
children
rural
area
well
character
present
studi
undertaken
describ
profil
hhv
respiratori
virus
associ
hospitalbas
cap
noncap
among
infant
young
children
rural
area
china
use
comprehens
sensit
molecular
diagnost
techniqu
aspect
studi
perform
accord
nation
ethic
regul
approv
institut
review
board
centr
diseas
control
prevent
china
ethic
committe
wenzhou
medic
colleg
particip
receiv
written
inform
regard
purpos
studi
right
confidenti
individu
written
inform
consent
obtain
parent
guardian
particip
wenl
locat
rural
area
southeast
coast
china
sub
tropic
monsoon
climat
popul
approxim
accord
world
health
organis
clinic
criteria
cap
defin
presenc
pneumon
infiltr
alveolar
parenchym
chest
radiographi
simultan
sign
andor
symptom
acut
infect
read
xray
film
specialist
blind
clinic
result
cap
patient
also
select
accord
set
necessari
criteria
base
respiratori
symptom
ie
dyspnea
respiratori
distress
cough
tachypnea
evid
parenchym
infiltr
chest
radiographi
total
highqual
induc
sputum
sampl
squamou
epitheli
cell
leukocyt
per
lowpow
field
obtain
hospitalis
infant
young
children
respiratori
ill
wenl
hospit
septemb
april
two
hundr
seventythre
sampl
preselect
hospitalis
children
patient
diagnos
non
typic
bacteri
cap
within
hr
admiss
sampl
hospit
children
patient
set
control
group
clinic
diagnosi
noncap
patient
base
chest
xray
respiratori
sign
asthma
chronic
bronchiti
cystic
fibrosi
admiss
typic
bacteri
cap
base
microbiolog
test
treatment
algorithm
elev
leukocyt
count
exclud
addit
patient
select
immunocompet
baselin
neg
tb
test
immunosuppress
typic
bacteri
cap
patient
exclud
children
presum
nosocom
cap
lowerqu
induc
sputum
sampl
also
exclud
sputum
product
induc
inhal
hyperton
salin
solut
sputum
sampl
week
hospit
admiss
aspir
nostril
sputum
collect
method
describ
detail
elsewher
nucleic
acid
extract
viru
transport
medium
vtm
use
qiaamp
minelut
viru
spin
kit
qiagen
germani
accord
manufactur
instruct
polymeras
chain
reaction
pcr
multiplex
pcr
perform
describ
previous
hhv
includ
varicella
zoster
viru
vzv
cmv
epstein
barr
viru
ebv
adenovirus
adv
ifv
type
b
piv
type
rsv
picornavirus
pic
includ
enterovirus
rhinovirus
use
multipl
rtpcr
assay
tabl
human
coronaviru
hcov
human
metapneumoviru
hmpv
use
rtpcr
hbov
use
nestedpcr
assay
tabl
posit
viru
stock
dna
neg
control
vtm
set
pcr
assay
includ
survey
possibl
laboratori
contamin
method
report
previous
valid
lab
amplicon
posit
pic
gelpurifi
dna
sequenc
use
qiaquick
gel
extract
qiagen
germani
accord
manufactur
instruct
dna
sequenc
perform
specif
primer
use
abi
prism
bigdy
termin
cycl
sequenc
reaction
kit
version
abi
prism
dna
sequenc
appli
biosystem
foster
citi
ca
follow
manufactur
instruct
enterovirus
ev
rhinovirus
identifi
base
sequenc
align
amplicon
elig
classif
clinic
syndrom
pneumonia
determin
origin
record
item
medic
histori
examin
databas
frequenc
distribut
viral
pathogen
cap
noncap
analys
test
fisher
exact
test
statist
analys
perform
statist
packag
social
scienc
spss
spss
inc
chicago
il
statist
signific
assess
tukey
test
pvalu
consid
statist
signific
sampl
collect
hospitalis
patient
sever
cap
n
noncap
n
wenl
area
septemb
april
age
sex
distribut
shown
tabl
mean
age
cap
patient
year
standard
deviat
year
day
year
mean
age
non
cap
patient
year
standard
deviat
year
day
year
cap
case
infant
less
month
age
male
mean
admiss
day
fever
day
standard
deviat
day
day
cap
patient
receiv
antibiot
admiss
none
posit
tb
pcr
substanti
broaden
viral
detect
rate
sputum
sampl
diagnost
specimen
virus
identifi
cap
subject
noncap
control
subject
shown
tabl
cap
sampl
test
cmv
rsv
ebv
hbov
rv
commonli
detect
virus
adv
hmpv
hpiv
inf
ab
ev
also
found
sampl
posit
vzv
test
noncap
sampl
cmv
rsv
ebv
domin
virus
inf
inf
ab
hbov
hmpv
rhinoviru
also
detect
noncap
sampl
posit
hpiv
vzv
ev
adv
addit
found
preval
sever
viral
agent
rhinoviru
hbov
adv
cmv
among
sampl
cap
significantli
higher
noncap
control
group
p
preval
inf
b
among
sampl
noncap
significantli
higher
cap
group
p
total
cap
case
posit
hhv
account
hospitalis
infant
young
children
cap
includ
studi
noncap
case
howev
also
identifi
posit
hhv
among
respiratori
virus
rsv
domin
cap
noncap
group
present
significantli
less
frequent
hhv
studi
epidemiolog
profil
viru
infect
distribut
virus
age
season
studi
characteris
figur
signific
differ
found
flua
piconaviru
enterovirusrhinoviru
piv
hmpv
among
variou
age
group
cap
case
figur
howev
infect
rate
hbov
adv
show
peak
among
cap
patient
age
month
year
p
contrast
rsv
detect
peak
infant
group
month
cap
decreas
significantli
advanc
age
addit
signific
differ
hsv
cmv
observ
among
variou
age
group
cap
case
figur
howev
rate
infect
ebv
increas
age
among
cap
case
p
infect
rate
cmv
ebv
among
children
older
year
distribut
virus
age
among
control
group
noncap
also
investig
figur
signific
differ
rsv
ebv
cmv
shown
among
variou
age
group
noncap
case
howev
rate
infect
increas
age
similar
cap
group
among
sampl
cap
case
season
distribut
virus
investig
figur
septemb
april
found
peak
rsv
winter
spring
hbov
pic
autumn
hmpv
spring
addit
ebv
frequent
detect
autumn
infect
reach
height
winter
howev
found
signific
differ
cmv
detect
among
sampl
differ
season
interestingli
coinfect
found
cap
case
noncap
case
tabl
singl
viru
infect
detect
sampl
cap
case
cmv
hbov
studi
coinfect
patient
found
infect
virus
virus
virus
virus
virus
virus
addit
hhv
detect
coinfect
agent
respiratori
virus
among
rsv
infect
cap
case
hhv
case
hbov
case
common
concomitantli
detect
virus
significantli
higher
coinfect
among
noncap
group
clinic
manifest
cap
patient
includ
cough
fever
asthma
sputum
case
also
show
sign
diarrhoea
rhinorrhoea
dyspnea
rale
data
shown
sinc
high
viru
detect
rate
coinfect
rate
among
sampl
cap
noncap
group
studi
tabl
difficult
associ
clinic
symptom
patient
cap
individu
viru
infect
howev
preval
sever
viral
agent
rhinoviru
hbov
adv
cmv
among
sampl
cap
drastic
higher
noncap
control
group
p
addit
preval
rsv
coinfect
hhv
hbov
among
cap
group
significantli
higher
among
noncap
control
p
data
indic
sever
viral
agent
hbov
cmv
may
contribut
occurr
cap
cap
common
sever
develop
area
develop
area
major
caus
death
among
infant
children
rural
area
previou
investig
paediatr
cap
us
europ
emphasis
import
infect
common
respiratori
virus
rsv
inf
piv
adv
role
hhv
recent
identifi
virus
hbov
caus
cap
remain
controversi
studi
viral
preval
sputum
specimen
childhood
non
typic
bacteri
cap
investig
use
sensit
molecular
diagnost
method
hhv
respiratori
virus
virus
detect
children
surpris
consid
sampl
includ
highli
select
discoveri
viral
etiolog
addit
hhv
detect
studi
knowledg
first
comprehens
studi
preval
hhv
sputum
sampl
among
infant
young
children
cap
report
describ
detect
dna
sever
hhv
respiratori
sampl
focus
immunosuppress
individu
adult
cap
studi
screen
dna
hhv
sampl
among
infant
young
children
cap
use
sensit
multipl
pcr
assay
hhv
consid
vzv
detect
highest
posit
rate
found
cmv
infect
cmv
infect
usual
congenit
show
signific
differ
among
variou
age
group
studi
data
consist
previou
report
addit
report
cmv
detect
viral
agent
among
cap
case
cap
case
respect
furthermor
preval
cmv
among
sampl
cap
significantli
higher
noncap
control
group
preval
rsv
coinfect
hhv
among
cap
group
drastic
higher
among
noncap
control
p
data
suggest
associ
infect
hhv
especi
cmv
cap
infant
children
comprehens
studi
search
virus
sampl
among
infant
children
cap
rural
area
studi
common
recent
identifi
virus
associ
acut
respiratori
infect
screen
use
molecular
method
result
consist
previou
studi
conduct
china
area
show
mostdetect
agent
rsv
follow
hbov
rv
hmpv
adv
sampl
infant
children
cap
rsv
hbov
also
domin
virus
detect
sampl
noncap
group
moreov
data
show
higher
hbov
detect
rate
compar
previou
report
preval
hbov
among
sampl
cap
significantli
higher
noncap
control
group
similar
trend
also
observ
preval
rhinoviru
adv
among
sampl
cap
compar
noncap
control
group
unlik
previou
data
preval
hcov
among
sampl
significantli
lower
present
studi
differ
might
primarili
due
specimen
vs
nasopharyng
aspir
nasopharyng
wash
meantim
impact
factor
area
durat
studi
period
infect
could
rule
one
interest
find
present
studi
hhv
coinfect
found
cap
case
compar
rate
previou
etiolog
studi
childhood
cap
clinic
consequ
mix
infect
fulli
understood
yet
evid
suggest
mix
viral
infect
lead
sever
condit
individu
viral
infect
studi
unabl
determin
whether
hhv
reactiv
latent
reservoir
anoth
respiratori
viru
infect
immunosuppress
condit
caus
hhv
infect
increas
potenti
risk
respiratori
viru
infect
consequ
difficult
estim
true
associ
clinic
manifest
viru
infect
time
understand
detect
virus
sampl
pcr
necessarili
mean
caus
agent
concomit
cap
sampl
includ
studi
may
repres
part
hospit
infant
children
cap
hospit
evalu
real
pathogen
role
play
viru
hospit
children
cap
studi
noncap
hospit
children
chronic
respiratori
ill
set
control
group
howev
studi
still
two
major
limit
one
limit
studi
viral
detect
nonhospitalis
children
due
limit
ethic
patient
bacteri
cap
would
provid
control
group
studi
includ
therefor
viral
agent
detect
studi
may
repres
asymptomat
persist
prolong
shed
situat
also
possibl
evalu
exact
import
viru
respons
cap
case
nevertheless
believ
overal
studi
highlight
import
hhv
mainli
cmv
respiratori
virus
children
cap
anoth
limit
studi
sampl
collect
summer
could
lead
miss
viral
agent
parainfluenza
virus
enterovirus
summari
studi
preval
hhv
respiratori
virus
infant
young
children
cap
identifi
detect
viru
case
particip
cmv
ebv
rsv
hbov
clearli
predomin
contribut
significantli
spectrum
cap
rural
area
china
although
hhv
commonli
identifi
pathogen
studi
previous
thought
typic
caus
cap
immunocopet
individu
studi
requir
determin
relationship
presenc
hhv
sever
diseas
thu
clinic
signific
hhv
infect
coinfect
receiv
greater
attent
futur
treatment
prevent
studi
cap
infant
children
